What is the treatment for dyshidrotic dermatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Dyshidrotic Dermatitis

Topical corticosteroids are the first-line treatment for dyshidrotic dermatitis, with potency selection based on severity and location. 1, 2

First-Line Treatment Options

Topical Corticosteroids

  • Use medium to high potency topical corticosteroids for acute flares of dyshidrotic dermatitis 1
  • Apply twice daily until symptoms improve, then taper to maintenance therapy 1
  • For maintenance, consider intermittent use (twice weekly) to prevent relapses 1
  • Choose the least potent preparation that effectively controls symptoms 2
  • For severe flares, high potency steroids like betamethasone dipropionate or clobetasol propionate can be effective 1

Emollients and Skin Care

  • Apply emollients after bathing to provide a surface lipid film that reduces water loss 2
  • Use dispersible creams as soap substitutes, avoiding regular soaps and detergents 2
  • Keep nails short to minimize trauma and secondary infection risk 2

Management of Acute Vesicular Phase

For Weeping Lesions

  • Potassium permanganate soaks at 1:10,000 concentration for weeping vesicular lesions 3
  • Apply particularly for cases with fissures to accelerate wound closure 3
  • Use as antiseptic baths or compresses to treat vesicular lesions 3

Second-Line and Refractory Disease Treatment

Topical Calcineurin Inhibitors

  • Tacrolimus 0.1% ointment applied once daily to affected areas 1
  • Particularly useful for areas where prolonged steroid use is concerning 1

Phototherapy Options

  • Oral PUVA therapy has shown significant improvement in 81-86% of patients with hand and foot eczema 2
  • Narrowband UVB may be considered, showing a 75% reduction in mean severity scores in some studies 2
  • Oral PUVA has been shown to be superior to UVB in prospective controlled studies 2

For Secondary Infection

  • For bacterial superinfection, flucloxacillin is usually the most appropriate antibiotic 2
  • Use erythromycin when there is resistance to flucloxacillin or in patients with penicillin allergy 2
  • For herpes simplex virus infection, administer acyclovir early in the course of disease 2

Management of Triggers and Exacerbating Factors

Avoidance Strategies

  • Identify and avoid contact irritants and allergens 2, 4
  • Consider patch testing in cases unresponsive to standard treatment 1, 4
  • Avoid extremes of temperature and irritant clothing 2

Dietary Considerations

  • Consider low-cobalt and/or low-nickel diet in patients with metal hypersensitivity 5
  • Dietary restrictions may help reduce flares in selected patients 5

Treatment Algorithm Based on Severity

Mild Cases

  • Moisturizers and low to medium potency topical steroids 3, 2
  • Avoid triggers and irritants 2

Moderate Cases

  • Medium to high potency topical steroids 1
  • Add potassium permanganate soaks for weeping vesicles 3
  • Consider tacrolimus ointment for steroid-sparing effect 1

Severe or Refractory Cases

  • High potency topical steroids for short periods 1, 2
  • Consider oral PUVA therapy 2
  • For severe pruritus, short-term sedating antihistamines may be useful as adjuvant therapy 2

Important Caveats

  • Potent and very high potency topical corticosteroids should be used with caution and for limited periods due to risk of side effects 1, 2
  • Combination therapy with antibiotics and steroids has not shown additional benefit compared to steroids alone 1
  • Bacteriological swabs are not routinely indicated but may be necessary if patients do not respond to treatment 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Dyshidrotic Eczema

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Potassium Permanganate Solution for Dyshidrotic Eczema

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.